SPADA, ANNAMARIA
 Distribuzione geografica
Continente #
EU - Europa 14.809
NA - Nord America 12.796
AS - Asia 11.418
SA - Sud America 1.041
AF - Africa 267
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 10
Totale 40.390
Nazione #
US - Stati Uniti d'America 12.163
GB - Regno Unito 5.413
CN - Cina 3.790
SG - Singapore 3.371
DE - Germania 2.055
IT - Italia 2.019
SE - Svezia 1.338
RU - Federazione Russa 1.081
HK - Hong Kong 982
VN - Vietnam 749
BR - Brasile 668
FR - Francia 619
IN - India 585
UA - Ucraina 526
TR - Turchia 483
CA - Canada 478
BD - Bangladesh 455
NL - Olanda 442
KR - Corea 387
IE - Irlanda 342
FI - Finlandia 311
EU - Europa 241
JP - Giappone 167
CI - Costa d'Avorio 145
CO - Colombia 145
ID - Indonesia 107
BE - Belgio 96
ES - Italia 91
DK - Danimarca 89
PL - Polonia 87
AR - Argentina 82
MX - Messico 80
GR - Grecia 56
EC - Ecuador 41
IQ - Iraq 40
AU - Australia 37
RO - Romania 35
CH - Svizzera 32
SA - Arabia Saudita 32
UZ - Uzbekistan 32
IL - Israele 31
PK - Pakistan 31
ZA - Sudafrica 29
AT - Austria 27
CL - Cile 24
PE - Perù 22
VE - Venezuela 21
MY - Malesia 20
MA - Marocco 19
PH - Filippine 19
TW - Taiwan 18
HU - Ungheria 17
BO - Bolivia 14
CZ - Repubblica Ceca 14
SK - Slovacchia (Repubblica Slovacca) 14
EG - Egitto 13
JM - Giamaica 13
PT - Portogallo 13
TH - Thailandia 13
JO - Giordania 12
KE - Kenya 12
KZ - Kazakistan 12
PY - Paraguay 12
NO - Norvegia 11
NZ - Nuova Zelanda 11
SI - Slovenia 11
TN - Tunisia 11
LT - Lituania 10
NP - Nepal 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
BG - Bulgaria 8
LU - Lussemburgo 8
LV - Lettonia 8
PA - Panama 8
RS - Serbia 8
SV - El Salvador 8
UY - Uruguay 8
AZ - Azerbaigian 7
HN - Honduras 7
MO - Macao, regione amministrativa speciale della Cina 7
PS - Palestinian Territory 7
CR - Costa Rica 6
KG - Kirghizistan 6
LB - Libano 6
TT - Trinidad e Tobago 6
AL - Albania 5
IR - Iran 5
MD - Moldavia 5
PR - Porto Rico 5
SC - Seychelles 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BY - Bielorussia 4
OM - Oman 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
AO - Angola 3
BS - Bahamas 3
GY - Guiana 3
Totale 40.558
Città #
Southend 5.005
Singapore 1.957
Chandler 1.165
Ashburn 1.123
Hong Kong 928
Beijing 790
San Jose 751
Milan 662
Seattle 625
Ann Arbor 529
Princeton 477
Dallas 421
Wilmington 421
Houston 414
Frankfurt am Main 369
Jacksonville 369
Council Bluffs 351
Dublin 336
Hanover 328
Santa Clara 328
Toronto 303
New York 278
Dearborn 257
Redmond 250
Bengaluru 248
Los Angeles 246
Mountain View 231
Nanjing 223
Fairfield 202
Ho Chi Minh City 198
Buffalo 195
Lauterbourg 195
Des Moines 171
Woodbridge 165
Sakarya 160
Serra 157
Hanoi 154
Moscow 149
Abidjan 144
Shanghai 140
Hefei 130
Boardman 128
Jinan 122
Somerville 122
Guangzhou 121
Bogotá 116
Redwood City 116
Shenyang 116
Tokyo 113
Andover 110
The Dalles 104
Helsinki 94
Columbus 92
Munich 92
Grafing 89
Berlin 87
Tianjin 84
Rome 82
Cangzhou 80
Nanchang 80
São Paulo 79
Brussels 78
Cambridge 64
Changsha 62
Hangzhou 62
Dong Ket 60
Hebei 60
Warsaw 60
Fuzhou 59
Phoenix 59
Eitensheim 55
Seoul 54
Ottawa 51
Pisa 51
Sunnyvale 51
Zhengzhou 50
Kiez 49
Jakarta 48
Athens 43
Chicago 40
Jiaxing 40
Turin 37
San Diego 36
Taizhou 35
Mumbai 34
Istanbul 32
Shenzhen 32
Hamburg 31
Montreal 31
Ningbo 31
Nuremberg 31
Nürnberg 31
Orem 31
Bitonto 30
Amsterdam 28
London 26
Wuhan 26
Atlanta 25
Kunming 25
Haikou 24
Totale 25.244
Nome #
Pseudohypoparathyroidism and GNAS epigenetic defects : clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients 656
Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia : first Italian series 651
Bone involvement and mineral metabolism in Williams’ syndrome 610
Biallelic expression of the Gsalpha gene in human bone and adipose tissue 426
Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors 408
β-arrestin 2 is required for dopamine receptor type 2 inhibitory effects on AKT phosphorylation and cell proliferation in pituitary tumors 388
Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion 370
G protein mutations in endocrine diseases 336
A Case Report of Severe Hypotonic Hyponatremia Secondary to Concomitant Intake of Desmopressin Replacement Therapy and Non-Steroidal Anti-Inflammatory Drugs 323
Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiency 310
Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein 307
Different expression of protein kinase A (PKA) regulatory subunits in normal and neoplastic thyroid tissues 292
Analysis of genetic variants of phosphodiesterase 11A (PDE11A) in acromegalic patients 289
The effect of calcimimetic R-568 on the functional role of the calcium-sensing receptor R990G polymorphism 284
The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation 278
Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors 275
PKA regulatory subunit R2B is required for murine and human adipocyte differentiation 272
Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly : effects on cardiovascular risk factors 271
Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease 271
R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism 265
Efficacia e tollerabilità della radiochirurgia con tecnica gamma-knife nell’acromegalia : studio con follow-up pari a 10 anni 265
Effect of growth hormone deficiency and recombinant hGH (rhGH) replacement on the hypothalamic-pituitary-adrenal axis in children with idiopathic isolated GH deficiency 264
Specific roles of Gi protein family members revealed by dissecting SST5 coupling in human pituitary cells 258
Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activity. 257
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas 255
Is the 250 μg ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders? 253
La vita transnasosfronoidale nei pazienti anziani affetti da adenoma ipofisario, è veramente un intervento a bassa morbidità e mortalità 252
Effect of recombinant hGH (rhGH) replacement on gonadal function in male patients with organic adult-onset GH deficiency 250
Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma 250
Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands 248
Severe water intoxication secondary to the concomitant intake of non-steroidal anti-inflammatory drugs and desmopressin : a case report and review of the literature 247
Prevalence of GH deficiency in cured acromegalic patients : impact of different previous treatments 245
Patients with macroprolactinaemia : clinical and radiological features 245
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells 240
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly 238
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells 238
The microRNA cluster C19MC is deregulated in parathyroid tumours 237
GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency 237
Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation 237
An alternate translation initiation site circumvents an amino-terminal DAX1 nonsense mutation leading to a mild form of X-linked adrenal hypoplasia congenita 236
Calcimimetic R-568 effects on activity of R990G polymorphism of calcium-sensing receptor 233
Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients 233
The Gsα gene: Predominant maternal origin of transcription in human thyroid gland and gonads 233
Ghrelin in human medullary thyroid carcinomas 232
Assessing the presence of abnormal regulation of cortisol secretion by membrane hormone receptors : in vivo and in vitro studies in patients with functioning and non-functioning adrenal adenoma 232
Evaluation of IGF-I levels during long-term somatostatin analogs treatment in patients with gastroenteropancreatic endocrine tumors 231
Tumour-associated fibroblasts contribute to neoangiogenesis in human parathyroid neoplasia 231
Effect of cyclic adenosine 3',5'-monophosphate/protein kinase a pathway on markers of cell proliferation in nonfunctioning pituitary adenomas 230
Thyrotropin-secreting pituitary adenomas : outcome of pituitary surgery and irradiation 230
A new structural rearrangement associated to Wolfram syndrome in a child with a partial phenotype 229
Polimorphisms of the calcium-sensing receptor gene and stones in primary hyperparathyroidism 225
Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy 225
A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment 224
The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalisation after somatostatin stimulation 223
Adiponectin expression in human fetal tissues during mid- and late gestation 221
Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2 220
d3-Growth hormone receptor polymorphism in acromegaly : effects on metabolic phenotype 219
Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations 219
Efficacy and tolerability of gamma knife radiosurgery in acromegaly : a 10-year follow-up study 217
An unusual case of recurrent autoimmune hypophysitis 217
Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation. 217
Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors 215
Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults 215
Isolation and characterization of cells coexpressing endothelial progenitors and parathyroid specific genes from human adult normal and tumoral parathyroids 215
Valutazione della funzione dell'asse ipotalamo-ipofisi-surrene in pazienti acromegalici sottoposti a trattamento chirurgico o medico con analoghi della somatostatina 214
Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acromegaly 214
GH response to oral glucose tolerance test : a comparison between patients with acromegaly and other pituitary disorders 212
Evaluation of proopiomelanocortin mRNA in the peripheral blood from patients with Cushing's syndrome of different origin 211
Analysis of GNAS1 and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine disorders 210
Adequacy of current postglucose GH nadir limit (< 1 microg/l) to define long-lasting remission of acromegalic disease 210
G protein oncogenes in pituitary tumors 209
High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells 208
Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients 206
Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia 204
Growth hormone replacement therapy in growth hormone deficient children and adults : effects on hemochrome 203
Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor gene 203
Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas 203
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 202
Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors : identification of one pancreatic ghrelinoma 202
Cytoskeleton protein Filamin A is required for efficient Somatostatin receptor type 2 internalization and recycling through Rab5 and Rab4 sorting endosomes in tumor somatotroph cells 201
Filamin A (FLNA) Plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells 200
Bone involvement in adult patients affected with Ehlers-Danlos syndrome 200
Circulating adiponectin levels and cardiovascular risk factors in acromegalic patients 199
Preliminary data on biochemical remission of acromegaly after somatostatin analogs withdrawal 199
Effects of 8-Cl-cAMP on growth and apoptotic process in poorly differentiated thyroid cencer cell lines 198
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas 196
G proteins and hormonal signalling in human pituitary tumors: genetic mutations and functional alterations 196
G protein oncogenes in acromegaly 196
Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac) 194
Single-Molecule Microscopy Reveals Dynamic FLNA Interactions Governing SSTR2 Clustering and Internalization 193
Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: Relationship with cell proliferation 193
Expression of parathyroid-specific genes in vascular endothelial progenitors of normal and tumoral parathyroid glands 192
Eight-year follow-up of a child with a GH/prolactin-secreting adenoma : efficacy of pegvisomant therapy 191
Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies 190
Double pituitary and conserved function in an adult patient with neurofibromatosis type 1 190
Effect of 9-cis retinoic acid on dopamine D2 receptor expression in pituitary adenoma cells 189
Analysis of the 206M polymorphic variant of the SLC26A6 gene encoding a Cl- oxalate transporter in patients with primary hyperparathyroidism 188
Protein Kinase A regulatory subunits in human adipose tissue : decreased R2B expression and activity in adipocytes from obese subjects 188
Evaluation of the Components of the Insulin-like Growth Factors System in GH-deficient Adults: Effects of Twelve-month rhGH Treatment 188
Gonadal structures in a fetus with complete androgen insensitivity syndrome and persistent Müllerian derivatives : comparison with normal fetal development 187
Totale 24.799
Categoria #
all - tutte 107.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.621


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021992 0 0 0 0 0 0 0 0 0 0 729 263
2021/20222.829 186 68 211 162 192 145 245 149 428 258 198 587
2022/20233.580 442 424 324 414 402 676 57 248 341 43 122 87
2023/20242.203 74 162 109 142 639 124 137 179 56 140 200 241
2024/20254.907 210 439 84 499 457 221 116 521 249 462 426 1.223
2025/202610.942 1.169 712 1.228 890 1.050 779 1.199 578 1.239 857 1.241 0
Totale 42.380